Remove companies regeneron-pharmaceuticals-inc
article thumbnail

Bankrupt 23andMe To Delist Stock After Regeneron Deal

Law 360

Bankrupt genetic testing provider 23andMe Inc. said Tuesday it will delist its stock from the Nasdaq exchange, following Regeneron Pharmaceuticals Inc.'s s agreement last week to buy the defunct company.

94
article thumbnail

Regeneron Wants COVID-19 Tech Patent Suit Axed

Law 360

Regeneron Pharmaceuticals Inc. wants a New York federal judge to toss a suit claiming it used poached technology in its development and testing of COVID-19 vaccines and treatments, saying the company is protected by a legal safe harbor.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In-House Counsel Jobs – Corporate Counsel Jobs

InHouseBlog

Senior Counsel , The Act-1 Group, Inc., Director of Legal – Corporate – Investment Advisory Firm , McCormack Schreiber Legal Search Inc. Associate GC – Multi-Faceted Real Estate Development and Services Company , Garrison & Sisson (Reston, VA). Compliance Counsel , Deerfield Management Company, L.P.

article thumbnail

Regeneron Rips DOJ's FCA Suit As 'Divorced From Reality'

Law 360

Regeneron Pharmaceuticals Inc. Department of Justice claiming the company withheld information about a drug's average sales price was "divorced from reality" and the practice the government was complaining about was commonplace. has told a Massachusetts federal judge that a False Claims Act suit brought by the U.S.

Divorce 52
article thumbnail

The Use of Mandated Public Disclosures of Clinical Trials as Prior Art Against Study Sponsors

Patently O

Pharmaceutical innovators are voicing concern that these disclosures are increasingly being used as prior art to invalidate patents arising out of, or otherwise relating to, these trials, in a manner that threatens to disincentivize investment in pharmaceutical innovation. By Chris Holman Salix Pharms., Norwich Pharms. Norwich Pharms.

Court 75
article thumbnail

No Discovery In Regeneron FCA Case Until 1st Circ. Rules

Law 360

A False Claims Act case against Regeneron Pharmaceuticals Inc. will freeze completely while the government and the company argue the appeal of a crucial legal question, the presiding judge said Wednesday.

article thumbnail

District Judge Rejects Regeneron Bid For Prosecutor Docs

Law 360

Regeneron Pharmaceuticals Inc. can't seek more information about a former prosecutor who helped file an anti-kickback lawsuit against the company, a Massachusetts federal judge has ruled, calling allegations that the attorney downloaded files relating to the case when he left for private practice a "minor" issue.